I agree that this site is using cookies. You can find further informations here.
X
Sukawa, Yasutaka
74  results:
Search for persons X
?
1

Analysis of Risk Factors for Immune-Related Adverse Events ..:

Shimozaki, Keitaro ; Sukawa, Yasutaka ; Sato, Yasunori...
Future Oncology.  17 (2021)  20 - p. 2593-2603 , 2021
Link: https://doi.org/10.2217/..
 
?
2

Prospective feasibility study of indigo naturalis ointment ..:

Hirata, Kenro ; Yamada, Yuka ; Hamamoto, Yasuo...
BMJ Supportive & Palliative Care.  13 (2021)  e3 - p. e1001-e1007 , 2021
Link: https://doi.org/10.1136/..
 
?
3

An Organoid Biobank of Neuroendocrine Neoplasms Enables Gen..:

Kawasaki, Kenta ; Toshimitsu, Kohta ; Matano, Mami...
Cell.  183 (2020)  5 - p. 1420-1435.e21 , 2020
Link: https://doi.org/10.1016/..
 
?
4

Multiple Immune-Related Adverse Events and Anti-Tumor Effic..:

Shimozaki, Keitaro ; Sukawa, Yasutaka ; Beppu, Noriko...
Cancer Management and Research.  12 (2020)  - p. 4585-4593 , 2020
Link: https://doi.org/10.2147/..
 
?
5

Clinical, Endoscopic, and Pathological Characteristics of I..:

Hayashi, Yukie ; Hosoe, Naoki ; Takabayashi, Kaoru...
Digestive Diseases and Sciences.  , 2020
Link: https://doi.org/10.1007/..
 
?
6

A Phase II Study of Regorafenib With a Lower Starting Dose ..:

Suzuki, Takeshi ; Sukawa, Yasutaka ; Imamura, Chiyo K....
Clinical Colorectal Cancer.  19 (2020)  1 - p. 13-21.e3 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Post-progression survival following second-line chemotherap..:

Kasuga, Akiyoshi ; Hamamoto, Yasuo ; Takeuchi, Ayano...
Investigational New Drugs.  36 (2018)  5 - p. 939-948 , 2018
Link: https://doi.org/10.1007/..
 
?
8

Clinical efficacy of immune checkpoint inhibitors in the tr..:

Togasaki, Kazuhiro ; Sukawa, Yasutaka ; Kanai, Takanori.
OncoTargets and Therapy.  11 (2018)  - p. 8239-8250 , 2018
Link: https://doi.org/10.2147/..
 
?
9

Clinical characteristics of Japanese patients with epitheli..:

Shiba, Satoshi ; Imaoka, Hiroshi ; Shioji, Kazuhiko...
BMC Cancer.  18 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
10

Divergent Routes toward Wnt and R-spondin Niche Independenc..:

Nanki, Kosaku ; Toshimitsu, Kohta ; Takano, Ai...
Cell.  174 (2018)  4 - p. 856-869.e17 , 2018
Link: https://doi.org/10.1016/..
 
?
11

Inter-evaluator heterogeneity of clinical diagnosis for loc..:

Hamamoto, Yasuo ; Nojima, Masanori ; Aoki, Yu...
Esophagus.  14 (2017)  4 - p. 324-332 , 2017
Link: https://doi.org/10.1007/..
 
?
12

Positive relationship between subsequent chemotherapy and o..:

Kasuga, Akiyoshi ; Hamamoto, Yasuo ; Takeuchi, Ayano...
Cancer Chemotherapy and Pharmacology.  79 (2017)  3 - p. 595-602 , 2017
Link: https://doi.org/10.1007/..
 
?
13

EZH2 expression is a prognostic biomarker in patients with ..:

Yamamoto, Itaru ; Nosho, Katsuhiko ; Kanno, Shinichi...
Oncotarget.  8 (2017)  11 - p. 17810-17818 , 2017
Link: https://doi.org/10.18632..
 
?
14

The Relation Between EZH2 Expression and Clinical Outcomes ..:

Yamamoto, Itaru ; Nosho, Katsuhiko ; Kurihara, Hiroyoshi...
Gastroenterology.  152 (2017)  5 - p. S1027 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Five-weekly S-1 plus cisplatin therapy combined with trastu..:

Miura, Yuji ; Sukawa, Yasutaka ; Hironaka, Shuichi...
Gastric Cancer.  21 (2017)  1 - p. 84-95 , 2017
Link: https://doi.org/10.1007/..
 
1-15